A specific THC/CBD formulation significantly reduced agitation in hospice-eligible people with advanced dementia during a 12-week Phase 2 trial.

Dr. Weiner reviews a recently published study on the potential of Cannabidiol (CBD) in treating fentanyl addiction. CBD's anti-inflammatory properties could revolutionize addiction therapy by providing a safe and effective treatment alternative that mitigates neuroinflammatory responses, offering hope in the battle against the opioid crisis.